Tenderwize
Back to tender search

Supply of pharmaceutical products for compassionate and early access use

31 CHU·Toulouse, France·EUR 450M·Deadline Apr 02, 2034 · 2776 days left·Restricted·Supplies·DPS
Sign up to saveOpen documents
High valueStructured notice only
Original notice title

France – Pharmaceutical products – FOURNITURE DE MEDICAMENTS en accès compassionnels et en accès précoces (ex-ATU)

65/100

Opportunity Score

Needs reviewHigh complexity
SuppliesDPSOpen
Why this score?

Opportunity

65 / 100

Complexity

70 / 100

Risk factors

Since the DPS has been running since 2017, many operators are already admitted, leading to intense competition in mini-...

DPS does not guarantee any contracts; each specific contract is awarded via separate mini-competitions. Estimated value...

Restricted procedure — pre-qualification required

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • EUR 450M estimated value
  • Dynamic Purchasing System (DPS)
  • Supplies contract
  • 1 lot
  • Duration until Apr 2034
  • Supply of pharmaceutical products under compassionate access and early access (ex-ATU) authorizations.
  • DPS covers all product categories (no breakdown).
Show full summary

This notice is a corrigendum extending a Dynamic Purchasing System (DPS) for the supply of pharmaceutical products for compassionate and early access use (ex-ATU) in France. The DPS, managed by CHU de Toulouse on behalf of the UniHA group, was originally established in 2017 and is now extended by 120 months (until April 2034). Estimated annual value is €450 million (€1.8 billion total over 10 years). The DPS is open to new operators, but existing participants are automatically retained. No procurement documents were analyzed, and key details (eligibility, award criteria) are missing from the provided data.

Risks

Since the DPS has been running since 2017, many operators are already admitted, leading to intense competition in mini-...

DPS does not guarantee any contracts; each specific contract is awarded via separate mini-competitions. Estimated value...

Restricted procedure — pre-qualification required

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Operators already admitted in the original DPS are automatically retained and do not need to reapply.

Administrative

  • New operators must submit an application via the e-procurement platform (www.marches-publics.gouv.fr).
  • All submissions must be made electronically.

Requirements may be incomplete.

Buyer

Name

31 CHU

Location

Toulouse, FRA

Buyer profile

Open profile

Identifier

26310012500016

Activity

Health

Lots (1)

LOT-0001

Supply of pharmaceutical products for compassionate and early access use

Single lot covering all pharmaceutical products for compassionate and early access (ex-ATU). The DPS is not divided into product categories. Estimated annual value: €450 million (HT). Total estimated value over 10 years: €1.8 billion.

SuppliesDPSEU fundedElectronic submission

EUR 450M

Estimated value

Duration

Apr 2024 - Apr 2034

Category

Pharmaceutical products

Deadline

Deadline Apr 02, 2034

Procurement Details

Publication date
01 Feb 2024
Languages
French

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
66960-2024

Documents (1)

Procurement document 1

Similar tenders

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3